TheEdgeResearch
Home / Stocks / NRTSF

Nobilis Health Corp. (NRTSF)

OTC Healthcare Medical - Care Facilities
$0.00 ▲ +1166.80%
Market Cap
$78
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
-328.99
52-Wk Range
0.000001-0.0001
CEO
Patrick Yoder
Country
CA
Currency
USD

Nobilis Health Corp. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Houston, CA. The stock last traded at $0.00, up 1166.80% on the session, giving a market capitalisation of $78. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 1.3%. Its beta of -328.99 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
3.34
Gross margin
62.4%
Operating margin
7.4%
Net margin
1.3%
Return on equity
Debt / equity
0.91
Current ratio
2.12
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
700
IPO date
2011-11-07
Headquarters
Houston, CA
About Nobilis Health Corp.

Nobilis Health Corp. focuses on the development and operation of ambulatory surgical centers, providing cutting-edge surgical solutions. The company owns and manages a diverse range of facilities, including both outpatient and acute care settings. Its business operations are divided into two primary segments: Medical Services and Marketing Services. The Medical Services division is responsible for the management of hospitals, outpatient clinics, and various other healthcare offerings. Complementing this, the Marketing Services segment delivers promotional strategies, patient educational programs, and comprehensive patient care coordination. Nobilis Health Corp. was established on March 16, 2007, and its corporate headquarters are located in Houston, TX.

Comparable companies

Nobilis Health Corp. is most often compared with the following Healthcare names:

ACUSAOBIAPYICDXIENCWLGBIMYMXPPIISDNISECI
More research on NRTSF
NRTSF technical analysis NRTSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →